Find Access for Eligible, Commercially Insured Patients

Bristol Myers Squibb (BMS) supports access to certain BMS oncology products through the BMS Oncology Co-Pay Assistance Program. The program provides financial assistance with the out-of-pocket deductibles, co-pay, or co-insurance costs for eligible patients who have been prescribed certain BMS oncology products.

Program at a Glance:

Enrolled patients only pay
$25 per product. The patient must
pay the first $25 of the co-pay for
each dose of a BMS medication covered by this Program.

Bristol Myers Squibb will cover the remaining amount up to a maximum of $25,000 per year, per patient,
per product.

Restrictions apply. Final determination of Program eligibility is based upon review of completed application. Please click here for full Terms and Conditions, including complete eligibility requirements.

Please note: The Program will cover the out-of-pocket expenses of the BMS product only. It does not cover the costs of any other healthcare provider charges or any other treatment costs. Patients may be responsible for non-drug-related out-of-pocket costs, depending on their specific healthcare benefits.

How Does It Work? It's Simple.

The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.